The sCelLiVE® Tissue Preservation Buffer is designed to maintain the integrity of fresh tissues without the need for chemical fixation, offering stable preservation for up to 72 hours and effectively simulating the natural physiological environment. This allows for high cell viability to be maintained even in sensitive samples. This sCelLiVE® Tissue Preservation Buffer enables gentle, prolonged preservation that is compatible with efficient dissociation.

Studies performed with brain tissue, both fresh and stored at 4°C for 24 and 72 hours, show that approximately 90% of cells remain alive after 72 hours in the Preservation Buffer, demonstrating its excellent capability to protect tissues over extended periods.

sCelLiVE Tissue Preservation Buffer

Key benefits of the sCelLiVE® Buffer

Simulation of the physiological environment, maintaining optimal conditions for cell survival for up to 72 hours. 
Gentle preservation, without altering viability or causing significant changes in cellular composition.
Versatility, compatible with practically all fresh and solid tissues used in biomedical research. 
Simple workflow, with a ready-to-use solution that avoids complex preparations or protocol optimization.

Area:

Omics, Single cell, Transcriptomics

Brand:

Consult our experts

Google reCaptcha: Invalid site key.

Related products

SOPHiA DDM GEN2

Analytical platform for clinical genomics that enables the detection, annotation, and interpretation of genomic variants using artificial intelligence to support patient diagnosis and treatment. Detailed Description SOPHiA DDM™ Platform is an advanced solution for precision medicine workflows, with a renewed interface, web access, and new functionalities to accelerate genomic data analysis. It offers end‑to‑end workflows…
SOPHIA Genetics

PGT-SR (Preimplantation Genetic Testing for Chromosomal Structural Rearrangements)

PGT‑SR (Preimplantation Genetic Testing for Structural Chromosomal Rearrangements) is a solution aimed at the analysis of structural chromosomal rearrangements in embryos. According to the product literature, it is based on single‑cell whole‑genome amplification and NGS sequencing to detect embryos from patients with chromosomal abnormalities and select euploid embryos for transfer, with the aim of reducing…
Yikon Genomics
Next Generation Sequencing (NGS)

MaReCs (Mapping allele with resolved carrier state test)

MaReCs® (Allelic Mapping with Resolved Carrier Status) is a PGT‑SR technology that first identifies aneuploid or euploid embryos and then analyses translocation breakpoints and SNP linkage to differentiate carrier from non‑carrier euploid embryos. Detailed Description Principle of operation MaReCs® combines ChromSwift® technology with NGS sequencing to perform a CNV analysis and subsequently an SNP linkage…
Yikon Genomics
Next Generation Sequencing (NGS)

KaryoSeq (Integrated solution for PGT-M, PGT-SR and PGT-A)

KaryoSeq™ is a next‑generation sequencing (NGS)‑based solution for preimplantation genetic testing that enables PGT‑M, PGT‑SR and PGT‑A within a single workflow. It is designed for the analysis of DNA extracted from 3 to 10 trophectoderm cells of human embryos at the blastocyst stage. Detailed Description Principle of operation KaryoSeq™ is based on the MARSALA principle…
Yikon Genomics
Next Generation Sequencing (NGS)